Image

The University of Alabama at Birmingham (UAB) Neuroinflammation in Parkinson's Disease-TSPO- Positron Emission Tomography (PET) Substudy

Join UAB's study on Parkinson's inflammation using PET scans.

Recruiting
30 years and older
All
Phase 1/2

This study at the University of Alabama at Birmingham (UAB) is focused on Parkinson’s Disease (PD), a brain disorder that affects movement. The research uses a special scan called Positron Emission Tomography (PET) combined with a tracer called [18F]DPA-714 to look at brain inflammation. Inflammation in the brain is when parts of the immune system, like microglia (a type of brain cell), become too active. The goal is to see if people with PD have more brain inflammation than healthy people.

Participants will be divided into three groups: 100 PD patients and 100 healthy volunteers for a baseline study, 67 PD patients for a follow-up study after 5 years, and 5 PD patients for a special analysis. The study checks if the brain’s inflammation affects PD symptoms over time.

  • Participants will have a one-time PET/MRI scan and provide blood and spinal fluid samples.
  • Follow-up scans for some participants will occur about 5 years later.
  • There are no restrictions based on age, sex, or ethnicity, but participants must be 30 or older.
Study details
    Parkinson Disease

NCT03457493

University of Alabama at Birmingham

22 August 2026

Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team


Email

View email

Phone

Phone country flag

View phone
Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.